MASS-FORMING CHRONIC PANCREATITIS: A CASE REPORT
Main Article Content
Abstract
Background: Mass-forming pancreatitis is a distinct clinical entity in which inflammation is localized, creating a focal mass. Differentiating mass-forming pancreatitis from pancreatic cancer remains one of the most significant challenges for radiologists. Due to its tumor-like presentation, patients are frequently misdiagnosed with malignancy.
Case report: We present a case of a 70-year-old female with a history of breast cancer who was admitted with obstructive jaundice. Ultrasound, CT scanner and magnetic resonance imaging revealed a mass in the pancreatic head associated with enlargement of the pancreatic body and tail. Laboratory findings showed elevated bilirubin; however, tumor markers (CEA, CA 19-9) and pancreatic enzymes (amylase, lipase) were within normal limits. Notably, initial blood work showed leukocytosis with an increased neutrophil percentage. Following biliary drainage to relieve the obstruction, subsequent tests revealed a persistent elevation in both the absolute white blood cell count and the eosinophil count (percentage and absolute), along with markedly high serum IgE and a borderline increase in IgG4 levels. Based on these findings, the patient was diagnosed with a suspected case of Type 1 autoimmune pancreatitis, characterized by concurrent peripheral eosinophilia and elevated serum IgE levels, which showed a favorable response to Corticosteroid therapy.
Conclusion: Type 1 autoimmune pancreatitis with eosinophilia and hyper-IgE can manifest as a mass-forming pancreatic lesion, mimicking pancreatic malignancy. Recognizing this specific clinical phenotype is crucial in clinical practice to ensure an accurate diagnosis and prevent unnecessary surgical interventions.
Article Details
Keywords
Autoimmune pancreatitis, eosinophilia, pancreatic cancer, mass-forming pancreatitis, IgE.
References
[2] Yarandi S.S, Runge T, Wang L et al. Increased incidence of benign pancreatic pathology following pancreaticoduodenectomy for presumed malignancy over 10 years despite increased use of endoscopic ultrasound. Diagn Ther Endosc, 2014, 2014: 701535. doi: 10.1155/2014/701535
[3] D’Onofrio M, Zamboni G, Tognolini A et al. Mass-forming pancreatitis: value of contrast-enhanced ultrasonography. World J Gastroenterol, 2006, 12 (26): 4181-4184. doi: 10.3748/wjg.v12.i26.4181
[4] Gallo C, Dispinzieri G, Zucchini N, Invernizzi P, Massironi S. Autoimmune pancreatitis: cornerstones and future perspectives. World J Gastroenterol, 2024, 30 (8): 817-832. doi: 10.3748/wjg.v30.i8.817
[5] Kuruma S, Kamisawa T, Tabata T et al. Allergen-specific IgE antibody serologic assays in patients with autoimmune pancreatitis. Intern Med, 2014, 53 (6): 541-543. doi: 10.2169/internalmedicine.53.0963
[6] Michailidou D, Schwartz D.M, Mustelin T, Hughes G.C. Allergic aspects of IgG4-related disease: implications for pathogenesis and therapy. Front Immunol, 2021, 12: 693192. doi: 10.3389/fimmu.2021.693192.